-
Injectable solution.
-
Terramycin® LA Injectable Solution is a patented formulation containing 200 mg oxytetracycline per ml.
-
Terramycin® LA Injectable Solution is indicated for the treatment of conditions caused by, or associated with, oxytetracycline-susceptible organisms.
Terramycin® LA Injectable Solution is recommended wherever prolonged antibiotic treatment is indicated,
or where for practical, economic, or veterinary reasons, frequent animal handling and repeat treatment is not
feasible.Cattle: For the treatment of tick-borne gallsickness (anaplasmosis), heartwater, pneumonia, footrot, joint
ill, navel ill and pink eye (infectious bovine keratoconjunctivitis).Swine: For the treatment of pneumonia, joint ill and navel ill.
Sheep and goats: For the treatment of heartwater, pneumonia, footrot, joint ill and navel ill.
-
Do not administer Terramycin® LA Injectable Solution to piglets on the same day that they are injected with iron.
Use only in cattle, sheep, goats and swine.
The meat of treated animals may not be used for human consumption within 28 days of the last treatment.
Milk from treated cows must not be used for human consumption within 5 days of the last treatment.
Although this remedy has been extensively tested under a large variety of conditions, failure thereof may ensue as a result of a wide range of reasons. If this is suspected, seek veterinary advice and notify the registration holder.
-
Use only as directed.
Do not inject intravenously. Terramycin® LA Injectable Solution is designed for intramuscular injection at the single dose rate of 1 ml/10 kg of live body mass of cattle, sheep, goats and swine, thus providing 20 mg oxytetracycline per kg live body mass. Subcutaneous administration will give the same effect as the intramuscular route, but swelling at the injection site could occur. However, in very young swine under 10 kg body mass, the subcutaneous injection route of administration is preferred. Normally, a single treatment of 1 ml/10 kg body mass will be sufficient for the treatment of susceptible disease conditions. Retreatment 72 hours following the initial injection may be given, if necessary, particularly in the case of pink eye (infectious bovine keratoconjunctivitis). Temporary localised swelling at the injection site may be observed. In slaughter animals the preferred site of injection is the neck.
Dosage:
Cattle: 1 ml/10 kg body mass. Intramuscular injections should be made deep into the fleshy part of the muscle. To minimise local tissue irritation, no more than 10 ml should be injected at any one site.
Swine: In pigs weighing up to 10 kg, administer 1 ml subcutaneously behind the ear. In pigs weighing in excess of 10 kg, administer 1 ml/10 kg body mass by intramuscular injection at one site. In swine over 100 kg, it is recommended that the dose be divided and administered into two injection sites.
NB: Do not administer more than 0,5 ml to piglets of less than 2 kg body mass.
Sheep and goats: Administer 1 ml/10 kg body mass by intramuscular injection at one site. In sheep and goats over 50 kg, it is recommended that the dose be divided and administered into two injection sites.
NB: For rapid recovery, a prompt and accurate diagnosis is essential. It is, therefore, always advisable to consult your veterinarian for a correct diagnosis.
-
Store below 30 °C. Characteristic of oxytetracycline solutions, some darkening of the preparation may occur during use without affecting potency.
-
20 ml
100 ml
500 ml
DISCLAIMER: ALTHOUGH GREAT CARE HAS BEEN TAKEN IN THE COMPILATION OF THIS DOCUMENT, READERS ARE REQUESTED TO REFER TO THE PACKAGE INSERT FOR COMPLETE DETAILS BEFORE USING THE SPECIFIC PRODUCT.
Ordering Products |
Fax no. for Orders: |
+27 21 427 6442 |
Email address for Orders: |
ZoetisOrders@zoetis.com |
Physical Address: |
Zoetis South Africa (Pty) Ltd. Co. Reg. No.: 2012/001825/07 |
6th Floor, North Wing, 90 Rivonia Road, Sandton, 2196. |
Tel: |
+27 11 245 3300 or 0860 ZOETIS (0860 963847) |
Terms of sale
Postal Address
Zoetis South Africa (Pty) Ltd
PostNet Suite 53
Private Bag 9976
Sandton
2146
- Argentina
- Australia
- Austria
- Belgium
- Bolivia
- Brazil
- Bulgaria
- Canada
- Chile
- China
- Colombia
- Costa Rica
- Croatia
- Czech Republic
- Denmark
- Ecuador
- Egypt
- Estonia
- Ethiopia
- Finland
- France
- Germany
- Ghana
- Greece
- Hungary
- India
- Indonesia
- Ireland
- Israel
- Italy
- Japan
- Kenya
- Latvia
- Liberia
- Lithuania
- Malawi
- Malaysia
- Mauritius
- Mexico
- Morocco
- Mozambique
- Netherlands
- New Zealand
- Nigeria
- Paraguay
- Peru
- Philippines
- Poland
- Portugal
- Romania
- Russia
- Serbia
- Singapore
- Slovakia
- Slovenia
- South Africa
- South Korea
- Spain
- Switzerland
- Taiwan
- Tanzania
- Thailand
- Turkey
- Uganda
- Ukraine
- United Kingdom
- United States
- Uruguay
- Vietnam
- Zambia
- Zimbabwe
You are leaving the country website to access another site in the group.
Regulatory constraints and medical practices vary from country to country. Consequently, the information provided on the site in which you enter may not be suitable for use in your country.